Nanoparticle-based method shows promise in DNA vaccine delivery

December 19, 2016

Scientists at Brigham and Women's Hospital have developed a novel method for delivering therapeutic molecules into cells. The method harnesses gold nanoparticles that are electrically activated, causing them to oscillate and bore holes in cells' outer membranes and allowing key molecules—such as DNA, RNA, and proteins—to gain entry. Unlike other approaches, the nanoparticles are not tethered to their biological cargo, a refinement that can boost therapeutic potency and effectiveness.

The research team, led by Hadi Shafiee, PhD, assistant professor at Brigham and Women's Hospital, together with first author Mohamed Shehata Draz, PhD, evaluated the technique's ability to deliver a DNA vaccine—specifically, one against the hepatitis C virus (HCV)—into mice. They found that it induced a strong immune response, reflected by high levels of anti-HCV antibodies and that secrete specific inflammatory hormones. Importantly, Shafiee and his colleagues detected no signs of toxicity in the mice throughout the study period, which lasted nearly 3 months.

"Our concept is unique," says Draz. "Both the electric field parameters and the nanoparticle properties can be augmented to perform other important functions, such as precisely removing cells or blood clots."

There is growing interest in DNA vaccines. First, they offer a potential alternative to conventional vaccines, which are sometimes constructed using weakened microbes—either whole or specific parts. These foreign substances can pose risks to patients, which could potentially be minimized if DNA—now readily synthesized in the laboratory—is used instead. DNA vaccines also show promise as a tool for taming cancer growth.

Although Draz, Shafiee, and their colleagues began by applying their novel nanoparticle method to DNA vaccines, they underscore its wide-ranging applications.

"One of the really exciting aspects of this new method is that it enables drug delivery into tissues or cells in a universal way," says Shafiee. "We are eager to explore its use for other important biological molecules, including RNA."

Explore further: 'Stealth' nanoparticles could improve cancer vaccines

More information: Mohamed Shehata Draz et al, Electrically Oscillating Plasmonic Nanoparticles for Enhanced DNA Vaccination against Hepatitis C Virus, Advanced Functional Materials (2016). DOI: 10.1002/adfm.201604139

Related Stories

'Stealth' nanoparticles could improve cancer vaccines

October 1, 2014

Cancer vaccines have recently emerged as a promising approach for killing tumor cells before they spread. But so far, most clinical candidates haven't worked that well. Now, scientists have developed a new way to deliver ...

Cancer vaccine packaged in minute particles

February 23, 2016

Leiden researchers have carried out successful tests using a new method of packaging a cancer vaccine in nanoparticles. The new vaccine has induced a strong immune reaction in mice. The researchers believe that this method ...

Hitchhiking vaccines boost immunity

February 17, 2014

Many vaccines, including those for influenza, polio, and measles, consist of a killed or disabled version of a virus. However, for certain diseases, this type of vaccine is ineffective, or just too risky.

New cancer vaccine one step closer

June 2, 2016

A team led by Monash University and the University of Queensland has developed a new approach to harnessing the body's immune system to fight disease that could pave the way for a new class of cancer vaccine.

Recommended for you

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.